PERSPECTA

News from every angle

Back to headlines

Merck and Gilead Announce Positive Phase 3 Results for Combination HIV Pill

Pharmaceutical companies Merck and Gilead have reported positive outcomes from their Phase 3 clinical trials for a new combination pill designed to treat HIV.

8 Jun, 21:44 — 8 Jun, 21:44
PostShare

Sources

Showing 1 of 1 sources